ORMPOramed Pharmaceuticals Inc.

CSNasdaq (XNAS)·USD

Identity

Security key: 19733
Ticker: ORMP
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2004-04-19
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ORMP

Detail

Enriched 2026-08-14 20:47

Market cap: $177,620,701.58
Shares outstanding (class): 41,597,354
Shares outstanding (weighted): 41,597,354
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 13
Location: NEW YORK, NY
Homepage: https://www.oramed.com
Description: Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

Market cap and share counts drift.

Funds holding this security

4 funds · 4 positions · $317.8K reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Micro-Cap ETF iShares Trust	IWC	$280.8K	0.02%	82,596 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$20.7K	0.01%	6,084 NS	FIGI
LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$9.1K	0.00%	2,680 NS	FIGI
JNL/DFA U.S. Small Cap Fund JNL Series Trust	—	$7.1K	0.00%	2,100 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERORMP
FIGI_COMPOSITEBBG000LRYR36
FIGI_SHARE_CLASSBBG001SK4M90
CIK0001176309
ISINUS68403P2039
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Oramed Pharmaceuticals is a biopharmaceutical company developing oral insulin, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.